Valens Semiconductor (VLN) Investor Day 2024 summary

Strategic vision and market positioning

• Plans to more than triple revenues by 2029, targeting $220M–$300M, with 4x–6x growth from 2024 levels, driven by expansion in Pro AV, industrial/machine vision, automotive, and medical markets.

• Focus on core technology: long-reach, high-performance, error-free connectivity, leveraging DSP-based solutions and leadership in standards like HDBaseT and MIPI A-PHY.

• Pro AV market leadership established, now expanding into larger markets such as video conferencing, automotive ADAS, industrial machine vision, and single-use medical devices, with combined TAMs exceeding $5B by 2029.

• M&A strategy targets synergistic, revenue-generating companies in Pro AV and industrial sectors, with $30M–$40M of 2029 revenue expected from acquisitions and recent acquisition of Acroname.

• Emphasis on standardization, ecosystem building, and a diversified customer base for long-term adoption and revenue stability.

Financial performance and guidance

• 2023 revenue reached $84.2M, with 2024 guidance of $57.2–$57.5M due to inventory adjustments and market transitions.

• Gross margin guidance for 2024 is 58–60%, with segment targets for 2029: Pro AV (65–75%), Industrial Machine Vision (55–65%), Automotive (35–45%), and new acquisitions (50–60%).

• Positive adjusted EBITDA expected at $110M–$120M annual revenue; 2029 EBITDA margin target is 15%–20%.

• 2025 revenue goal set at $71M–$76M, with 25%–33% growth over 2024, driven by recovery in Pro AV and ramp-up of new products.

• Strong cash and working capital position ($133M) supports both organic and inorganic growth, ongoing R&D, and market expansion.

Product innovation and market opportunities

• Launched VS6320 for USB 3.0 extension, targeting $350M TAM in video conferencing by 2029, with over 50 products embedding the chip.

• Automotive: Mercedes-Benz and Stoneridge as key customers; VA7000 chipset is first MIPI A-PHY compliant, opening $4.5B TAM by 2029.

• Industrial/machine vision: VA7000 and VS6320 address rising demand for high-bandwidth, real-time AI-enabled inspection, with $460M TAM by 2029.

• Single-use medical endoscopy seen as a long-term growth driver, with $625M TAM potential as industry shifts to disposable devices.

• Cross-segment technology reuse and standardization enable efficient R&D and market entry.